RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Fuji Pharma Co Stock

Fuji Pharma Co Liabilities 2025

Fuji Pharma Co Liabilities

44.44 B JPY

Ticker

4554.T

ISIN

JP3816200004

WKN

938283

In 2025, Fuji Pharma Co's total liabilities amounted to 44.44 B JPY, a 0.64% difference from the 44.16 B JPY total liabilities in the previous year.

Fuji Pharma Co Aktienanalyse

What does Fuji Pharma Co do?

Fuji Pharma Co Ltd is a Japanese company specializing in the healthcare industry. The company was founded in 2001 and is headquartered in Tokyo, Japan. It is listed on the Tokyo Stock Exchange and employs over 1,000 employees. Fuji Pharma's business model is to provide its customers with innovative and high-quality products that contribute to improving health and well-being. The company specializes in several business areas, including the development, manufacturing, and marketing of pharmaceutical products, production of OEM products for other companies, and manufacturing of dietary supplements and cosmetics. An important area for Fuji Pharma is the development and production of pharmaceuticals. The company ensures that its medications meet the highest requirements and international standards. This includes research and development of new products. The company has its own research department specializing in the development of medications that can be used in serious diseases such as cancer, diabetes, and cardiovascular diseases. In addition, Fuji Pharma is also involved in the production of OEM products for other companies. The company ensures the manufacture of medications and medical products for other pharmaceutical companies, meeting the highest quality standards and customer requirements. Fuji Pharma is proud to be a trusted partner for its customers and provides its services according to the requirements of its customers. In addition to these two divisions, Fuji Pharma also produces dietary supplements and cosmetics for the domestic and international markets. These products are designed for consumers who want to improve their health and well-being. The company places great emphasis on the development of natural and safe ingredients for its products and ensures the highest standards of quality and safety. Fuji Pharma has also specialized in the Japanese market for medical devices, particularly in the field of home respiratory devices. The company has developed a new generation of respiratory therapy devices that are safe and easy to use, providing better well-being and quality of life for patients with respiratory diseases. In addition to its business areas, Fuji Pharma also has various products in its portfolio that are known for their quality and effectiveness. One such product is "Efil," a medication used in the treatment of erectile dysfunction disorders. The medication is available in Japan and other Asian countries and has already been used by over 200,000 patients. Fuji Pharma continuously strives to improve its research and development activities and develop new innovative products and services for the healthcare industry. The company aims to bring its products and services to the international market and satisfy its customers in Japan and worldwide. Fuji Pharma Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Fuji Pharma Co's Liabilities

Fuji Pharma Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Fuji Pharma Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Fuji Pharma Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Fuji Pharma Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Fuji Pharma Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Fuji Pharma Co stock

What is the level of liabilities of Fuji Pharma Co this year?

Fuji Pharma Co has a debt balance of 44.44 B JPY this year.

What were the liabilities of Fuji Pharma Co compared to the previous year?

The liabilities of Fuji Pharma Co have increased by 0.64% increased compared to the previous year.

What are the consequences of high debt for investors of Fuji Pharma Co?

High liabilities can pose a risk for investors of Fuji Pharma Co, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Fuji Pharma Co?

Low liabilities mean that Fuji Pharma Co has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Fuji Pharma Co affect the company?

An increase in liabilities of Fuji Pharma Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Fuji Pharma Co affect the company?

A decrease in the liabilities of Fuji Pharma Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Fuji Pharma Co?

Some factors that can influence the liabilities of Fuji Pharma Co include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Fuji Pharma Co so important for investors?

The liabilities of Fuji Pharma Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Fuji Pharma Co take to modify the liabilities?

To change its liabilities, Fuji Pharma Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Fuji Pharma Co pay?

Over the past 12 months, Fuji Pharma Co paid a dividend of 42.5 JPY . This corresponds to a dividend yield of about 2.66 %. For the coming 12 months, Fuji Pharma Co is expected to pay a dividend of 44.61 JPY.

What is the dividend yield of Fuji Pharma Co?

The current dividend yield of Fuji Pharma Co is 2.66 %.

When does Fuji Pharma Co pay dividends?

Fuji Pharma Co pays a quarterly dividend. This is distributed in the months of April, October, April, October.

How secure is the dividend of Fuji Pharma Co?

Fuji Pharma Co paid dividends every year for the past 17 years.

What is the dividend of Fuji Pharma Co?

For the upcoming 12 months, dividends amounting to 44.61 JPY are expected. This corresponds to a dividend yield of 2.79 %.

In which sector is Fuji Pharma Co located?

Fuji Pharma Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fuji Pharma Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fuji Pharma Co from 12/1/2025 amounting to 22.5 JPY, you needed to have the stock in your portfolio before the ex-date on 9/29/2025.

When did Fuji Pharma Co pay the last dividend?

The last dividend was paid out on 12/1/2025.

What was the dividend of Fuji Pharma Co in the year 2024?

In the year 2024, Fuji Pharma Co distributed 37 JPY as dividends.

In which currency does Fuji Pharma Co pay out the dividend?

The dividends of Fuji Pharma Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Fuji Pharma Co

Our stock analysis for Fuji Pharma Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fuji Pharma Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.